Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Trodelvy
Pharma
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC
For now, approval in the PD-L1-positive population makes Trodelvy’s TNBC label broader than its rival. But AZ and Daiichi plan to catch up.
Angus Liu
Jun 24, 2026 5:00pm
Gilead's Trodelvy stumbles in first-line NSCLC
Jun 9, 2026 11:14am
AZ, Daiichi's Datroway approved in first-line TNBC
May 22, 2026 11:32am
In endometrial cancer, Merck and Kelun score with sac-TMT
May 18, 2026 11:21am
Merck partner Kelun touts ph. 3 win for ADC in first-line NSCLC
Nov 24, 2025 10:56am
Gilead's Trodelvy comes up short in breast cancer study
Nov 7, 2025 12:12pm
